Molecular mechanisms leading to ceftolozane/tazobactam resistance in clinical isolates of Pseudomonas aeruginosa from five Latin American countries

ObjectivesIdentify molecular mechanisms responsible for the in vitro non-susceptibility to ceftolozane/tazobactam (TOL) in a group of 158 clinical isolates of Pseudomonas aeruginosa from five Latin American countries collected before the introduction of TOL into the clinical practice.MethodsClinical...

Full description

Bibliographic Details
Published in:Frontiers in Microbiology
Main Authors: María F. Mojica, Elsa De La Cadena, Rafael Ríos, Juan Carlos García-Betancur, Lorena Díaz, Jinnethe Reyes, Cristhian Hernández-Gómez, Marcela Radice, Ana C. Gales, Paulo Castañeda Méndez, José M. Munita, Christian José Pallares, José R. W. Martínez, María Virginia Villegas
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2022.1035609/full